Streetbeat News

DXYZ

Destiny Tech100 Inc.

Industry

Asset Management

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Open

38.42

Mkt cap

411M

Volume

589K

High

37.87

P/E Ratio

209.89

52-wk high

105.00

Low

35.21

Div yield

N/A

52-wk low

7.75

OpenAI is reportedly in discussions for a new funding round that could value the company at over $100 billion. Thrive Capital and Microsoft are among the investors expected to contribute several billion dollars to the ChatGPT maker.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 7:30 pm

Elon Musk announced on X that SpaceX will move its headquarters from Hawthorne, California, to Starbase, Texas, due to unfavorable laws affecting families and companies.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 7:16 pm

Sequoia Capital is offering to buy up to $861 million of Stripe shares from its investors, providing liquidity to limited partners. This move reflects Sequoia's faith in Stripe's future despite the company's decision to remain private. Stripe handled over $1 trillion in payments in 2023, a 25% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 2:23 pm

Destiny Tech100 is being closely watched as traders circulate news of SpaceX's higher-than-expected valuation at $112 per share in a tender offer, valuing the company at $210 billion.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:23 pm

Multiple stocks on the New York Stock Exchange, including Berkshire Hathaway and Chipotle, experienced sudden trading halts due to technical issues. The NYSE is investigating the issue, which caused significant price drops in some stocks.

Portfolio Pulse from Piero Cingari

June 03, 2024 | 2:37 pm

Meta Platforms Inc.'s Chief AI Scientist, Yann LeCun, criticized OpenAI's early investor, Vinod Khosla, for supporting a closed-source approach to AI, motivated by financial gains and concerns over China's access to AI technology. LeCun advocates for open-source AI to ensure a diverse and democratic future. Meanwhile, Destiny Tech100 Inc. fund, which invests in tech companies including OpenAI, has seen a significant drop in value.

Portfolio Pulse from Rounak Jain

May 13, 2024 | 9:05 am

OpenAI CEO Sam Altman has declared a strong commitment to developing artificial general intelligence (AGI), stating financial costs, which could range from $500 million to $50 billion, are not a concern. Microsoft Corp. (NASDAQ:MSFT), as OpenAI's largest investor, has invested $13 billion in the AI startup. Altman's focus is on creating significant societal value through AGI, despite the high costs and challenges, including a lawsuit from Elon Musk alleging profit maximization for Microsoft.

Portfolio Pulse from Rounak Jain

May 03, 2024 | 9:58 am

Four Chinese AI startups, Zhipu AI, Moonshot AI, MiniMax, and 01.ai, have reached unicorn status, challenging US giants like OpenAI and Anthropic, backed by Microsoft (NASDAQ:MSFT) and Amazon (NASDAQ:AMZN) respectively. These startups, supported by domestic giants including Alibaba (NYSE:BABA), have seen valuations soar to over $1 billion each. Despite US restrictions on chip exports, these companies have secured necessary resources to continue their growth. Additionally, the US and China are set to hold high-level AI talks, amidst a backdrop of significant price cuts by Alibaba for its cloud services.

Portfolio Pulse from Benzinga Neuro

May 03, 2024 | 9:23 am

Travelers Companies, Inc. (TRV) shares fell by 8.1% after reporting mixed Q1 earnings, missing the consensus forecast. Other stocks showed significant movement, with INVO Bioscience, Inc. (INVO) and Edible Garden AG (EDBL) among the top gainers, while ICZOOM Group Inc. (IZM) and Sunshine Biopharma, Inc. (SBFM) led the losers. The market saw a wide range of stock performance, influenced by earnings reports, strategic agreements, and analyst ratings.

Portfolio Pulse from Avi Kapoor

April 17, 2024 | 5:36 pm

INVO Bioscience shares surged 73% in pre-market trading after reporting a 397% increase in quarterly revenue. Other stocks also showed significant movement in pre-market trading, with notable gainers including Mobile Global Esports, Chromocell Therapeutics, and Clene Inc., and losers like Connexa Sports Technologies and Dynatronics Corporation.

Portfolio Pulse from Avi Kapoor

April 17, 2024 | 10:13 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.